Life Science Instrumentation Market Size, Share, Opportunities, And Trends By Technology (Spectroscopy, Chromatography, Flow Cytometry, Others), By Application (Analytical Chemistry, Clinical Analysis, Environmental Testing, Food & Beverage Analysis, Others), By End Users (Hospitals, Research Institutes, Diagnostic Laboratories, Others), And By Geography - Forecasts From 2025 To 2030

Comprehensive analysis of demand drivers, supply-side constraints, competitive landscape, and growth opportunities across applications and regions.

Report CodeKSI061611899
PublishedSep, 2025

Description

Life Science Instrumentation Market Size:

The Life Science Instrumentation Market is projected to surge from USD 66.541 billion in 2025 to USD 89.679 billion by 2030, at a CAGR of 6.15%.

Instrumentation in life science holds a great advantage and opportunity for innovation and better quality treatment for patients. It can address different aspects that hold the key to cutting-edge research and innovative applications in the biotechnology and pharmaceutical industries among others. It is also used in the food and beverage industry and in the monitoring of the manufacturing process.

The demand for the life science instrumentation market is driven by the increasing investment by the pharmaceutical industry players for drug discovery and development, as it involves the use of the instruments. The demand is also driven by the rise in the increasing incidences of infectious diseases. The growing food and beverage industry attributes the growth of the demand in the market owing to the increasing consciousness among consumers about health. Moreover, the growing proteomics market and the increasing environmental concern have also supported the market. Furthermore, the increasing research and development by the key market players will lead to the life science instrumentation market size in the coming years.

Key Developments

Bruker Corporation launched the novel INVENIO X Fourier Transform Infrared system for research in molecular spectroscopy.

Bio-Rad Laboratories Inc. announced the innovative technology platform, BioPlex 2200Lyme Total Assay, to aid in the diagnosis of Lyme disease after receiving US FDA clearance.

The life science instrumentation market has been segmented based on technology, application, end-user, and geography. By technology, the market has been classified as spectroscopy, chromatography, flow cytometry, and others. By application, the market has been segmented as Analytical Chemistry, Clinical Analysis, Environmental Testing, Food & Beverage Analysis, and Others. By the end-user, the market has been segmented as Hospitals, Research Institutes, Diagnostic Laboratories, and Others.

Segmentation

  • By Technology
    • Spectroscopy
    • Chromatography
    • Flow Cytometry
    • Others
  • By Application
    • Analytical Chemistry
    • Clinical Analysis
    • Environmental Testing
    • Food and Beverage Analysis
    • Others
  • By End-Users
    • Hospitals
    • Research Institutes
    • Diagnostic Laboratories
    • Others
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • United Kingdom
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Others
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Indonesia
      • Thailand
      • Others

Frequently Asked Questions (FAQs)

Table Of Contents

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. LIFE SCIENCE INSTRUMENTATION MARKET BY TECHNOLOGY

5.1. Introduction

5.2. Spectroscopy

5.3. Chromatography

5.4. Flow Cytometry

5.5. Others

6. LIFE SCIENCE INSTRUMENTATION MARKET BY APPLICATION

6.1. Introduction

6.2. Analytical Chemistry

6.3. Clinical Analysis

6.4. Environmental Testing

6.5. Food and Beverage Analysis

6.6. Others

7. LIFE SCIENCE INSTRUMENTATION MARKET BY END-USERS

7.1. Introduction

7.2. Hospitals

7.3. Research Institutes

7.4. Diagnostic Laboratories

7.5. Others

8. LIFE SCIENCE INSTRUMENTATION MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. United Kingdom

8.4.4. Spain

8.4.5. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Shimadzu Corporation

10.2. Bio-Rad Laboratories, Inc.

10.3. Becton, Dickinson and Company

10.4. PerkinElmer, Inc.

10.5. Danaher Corporation

10.6. Hitachi High-Technologies Corporation 

10.7. Thermo Fisher Scientific Inc.

10.8. Bruker Corporation

10.9. General Electric Company

11. APPENDIX

11.1. Currency 

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology 

11.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

Companies Profiled

Shimadzu Corporation

Bio-Rad Laboratories, Inc.

Becton, Dickinson and Company

PerkinElmer, Inc.

Danaher Corporation

Hitachi High-Technologies Corporation 

Thermo Fisher Scientific Inc.

Bruker Corporation

General Electric Company

Related Reports